EGX: MPCI Statistics

Total Valuation

Memphis Pharmaceuticals & Chemical Industries has a market cap or net worth of EGP 1.33 billion. The enterprise value is 859.93 million.

Market Cap	1.33B
Enterprise Value	859.93M

Important Dates

The next estimated earnings date is Monday, February 10, 2025.

Earnings Date	Feb 10, 2025
Ex-Dividend Date	Nov 13, 2024

Share Statistics

Memphis Pharmaceuticals & Chemical Industries has 22.75 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	22.75M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	1.84%
Owned by Institutions (%)	n/a
Float	18.55M

Valuation Ratios

The trailing PE ratio is 1.07.

PE Ratio	1.07
Forward PE	n/a
PS Ratio	0.30
PB Ratio	1.14
P/TBV Ratio	4.74
P/FCF Ratio	11.35
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 2.64, with an EV/FCF ratio of 7.34.

EV / Earnings	2.80
EV / Sales	0.79
EV / EBITDA	2.64
EV / EBIT	2.79
EV / FCF	7.34

Financial Position

The company has a current ratio of 1.31, with a Debt / Equity ratio of 0.50.

Current Ratio	1.31
Quick Ratio	1.10
Debt / Equity	0.50
Debt / EBITDA	0.44
Debt / FCF	1.22
Interest Coverage	21.61

Financial Efficiency

Return on equity (ROE) is 147.62% and return on invested capital (ROIC) is 68.50%.

Return on Equity (ROE)	147.62%
Return on Assets (ROA)	18.11%
Return on Capital (ROIC)	68.50%
Revenue Per Employee	7.56M
Profits Per Employee	2.14M
Employee Count	144
Asset Turnover	1.02
Inventory Turnover	3.59

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -24.91% in the last 52 weeks. The beta is 0.13, so Memphis Pharmaceuticals & Chemical Industries's price volatility has been lower than the market average.

Beta (5Y)	0.13
52-Week Price Change	-24.91%
50-Day Moving Average	53.95
200-Day Moving Average	62.45
Relative Strength Index (RSI)	59.02
Average Volume (20 Days)	386,961

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Memphis Pharmaceuticals & Chemical Industries had revenue of EGP 1.09 billion and earned 307.55 million in profits. Earnings per share was 54.68.

Revenue	1.09B
Gross Profit	432.62M
Operating Income	308.12M
Pretax Income	378.95M
Net Income	307.55M
EBITDA	325.87M
EBIT	308.12M
Earnings Per Share (EPS)	54.68

Full Income Statement

Balance Sheet

The company has 611.96 million in cash and 143.29 million in debt, giving a net cash position of 468.67 million or 20.60 per share.

Cash & Cash Equivalents	611.96M
Total Debt	143.29M
Net Cash	468.67M
Net Cash Per Share	20.60
Equity (Book Value)	288.51M
Book Value Per Share	51.29
Working Capital	292.79M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 143.82 million and capital expenditures -26.73 million, giving a free cash flow of 117.09 million.

Operating Cash Flow	143.82M
Capital Expenditures	-26.73M
Free Cash Flow	117.09M
FCF Per Share	5.15

Full Cash Flow Statement

Margins

Gross margin is 39.73%, with operating and profit margins of 28.30% and 28.24%.

Gross Margin	39.73%
Operating Margin	28.30%
Pretax Margin	34.80%
Profit Margin	28.24%
EBITDA Margin	29.93%
EBIT Margin	28.30%
FCF Margin	10.75%

Dividends & Yields

This stock pays an annual dividend of 4.00, which amounts to a dividend yield of 6.77%.

Dividend Per Share	4.00
Dividend Yield	6.77%
Dividend Growth (YoY)	100.00%
Years of Dividend Growth	3
Payout Ratio	3.96%
Buyback Yield	n/a
Shareholder Yield	6.77%
Earnings Yield	23.15%
FCF Yield	8.81%

Dividend Details

Stock Splits

The last stock split was on May 14, 2009. It was a forward split with a ratio of 1.5.

Last Split Date	May 14, 2009
Split Type	Forward
Split Ratio	1.5

Scores

Memphis Pharmaceuticals & Chemical Industries has an Altman Z-Score of 2.32. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.32
Piotroski F-Score	n/a